Summit Global Investments’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-1,688
Closed -$1.14M 466
2021
Q4
$1.14M Buy
1,688
+956
+131% +$582K 0.07% 216
2021
Q3
$480K Buy
+732
New +$625K 0.04% 316

Other funds holding AGL

Summit Global Investments's AGL Position: Q1 2022 in Review

Summit Global Investments sold out of Agilon Health (AGL) in Q1 2022, closing a stake of 1,688 shares — an estimated $1.14M sold.

Summit Global Investments first reported a position in AGL in Q3 2021 and held it in 2 quarters. The position peaked at $1.14M in Q4 2021. 121 funds tracked by Wall St. Rank hold AGL as of Q1 2022.

  • Summit Global Investments reported no remaining Agilon Health position as of Q1 2022 after selling out during the quarter.
  • Summit Global Investments sold 1,688 Agilon Health shares in Q1 2022, an estimated $1.14M.
  • Summit Global Investments first reported a position in Agilon Health in Q3 2021 and held it in 2 quarters.
  • Summit Global Investments's Agilon Health position peaked at $1.14M in Q4 2021.
  • 121 funds tracked by Wall St. Rank held Agilon Health as of Q1 2022.

Based on Summit Global Investments's 13F filing for Q1 2022, filed 29 Apr 2022.